Evidence map›Paper›PMID 32940030›Full record

ArticleACS applied materials & interfaces2020

Lipid-Bicelle-Coated Microfluidics for Intracellular Delivery with Reduced Fouling.

Jason N Belling, Liv K Heidenreich, Jae Hyeon Park, Lisa M Kawakami, Jack Takahashi, Isaura M Frost, Yao Gong, Thomas D Young, Joshua A Jackman, Steven J Jonas and 2 more

Open access · greenAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Microfluidic and Nanofluidic Intracellular Delivery.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Jason N BellingCalifornia NanoSystems Institute, University of California, Los Angeles, Los Angeles, California 90095, United States.
Liv K HeidenreichCalifornia NanoSystems Institute, University of California, Los Angeles, Los Angeles, California 90095, United States.
Jae Hyeon ParkCalifornia NanoSystems Institute, University of California, Los Angeles, Los Angeles, California 90095, United States.ORCID http://orcid.org/0000-0002-2266-943X
Lisa M KawakamiCalifornia NanoSystems Institute, University of California, Los Angeles, Los Angeles, California 90095, United States.
Jack TakahashiCalifornia NanoSystems Institute, University of California, Los Angeles, Los Angeles, California 90095, United States.
Isaura M FrostCalifornia NanoSystems Institute, University of California, Los Angeles, Los Angeles, California 90095, United States.ORCID http://orcid.org/0000-0003-2851-1008
Yao GongCalifornia NanoSystems Institute, University of California, Los Angeles, Los Angeles, California 90095, United States.
Thomas D YoungCalifornia NanoSystems Institute, University of California, Los Angeles, Los Angeles, California 90095, United States.ORCID http://orcid.org/0000-0002-3234-7418
Joshua A JackmanSchool of Chemical Engineering, Sungkyunkwan University, Suwon 16419, Republic of Korea.ORCID http://orcid.org/0000-0002-1800-8102
Steven J JonasDepartment of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90095, United States.ORCID http://orcid.org/0000-0002-8111-0249
Nam-Joon ChoSKKU-UCLA-NTU Precision Biology Research Center, Sungkyunkwan University, Suwon 16419, Republic of Korea.ORCID http://orcid.org/0000-0002-8692-8955
Paul S WeissCalifornia NanoSystems Institute, University of California, Los Angeles, Los Angeles, California 90095, United States.ORCID http://orcid.org/0000-0001-5527-6248
California NanoSystems Institute · USNanyang Technological University · SGSungkyunkwan University · KR

Funding

Micro- to Nanoscale Neurochemical SensorsR01DA045550 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANDREWS, ANNE MILASINCIC · 2017 to 2021
$5.8M
Nanoscience-Inspired Acoustofluidic Assembly Lines for Gene and Cellular TherapiesDP5OD028181 · OD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JONAS, STEVEN JOHN · 2019 to 2023
$1.9M
Site-Specific Correction of Sickle Cell Disease Using Acoustofludic Gene DeliveryF31HL149356 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BELLING, JASON NATHANIEL · 2019 to 2020
$71k
NHLBI NIH HHS F31 HL149356NIDA NIH HHS R01 DA045550NIH HHS DP5 OD028181
6 · The paper itself

Abstract

Innovative technologies for intracellular delivery are ushering in a new era for gene editing, enabling the utilization of a patient's own cells for stem cell and immunotherapies. In particular, cell-squeezing platforms provide unconventional forms of intracellular delivery, deforming cells through microfluidic constrictions to generate transient pores and to enable effective diffusion of biomolecular cargo. While these devices are promising gene-editing platforms, they require frequent maintenance due to the accumulation of cellular debris, limiting their potential for reaching the throughputs necessary for scalable cellular therapies. As these cell-squeezing technologies are improved, there is a need to develop next-generation platforms with higher throughput and longer lifespan, importantly, avoiding the buildup of cell debris and thus channel clogging. Here, we report a versatile strategy to coat the channels of microfluidic devices with lipid bilayers based on noncovalent lipid bicelle technology, which led to substantial improvements in reducing cell adhesion and protein adsorption. The antifouling properties of the lipid bilayer coating were evaluated, including membrane uniformity, passivation against nonspecific protein adsorption, and inhibition of cell attachment against multiple cell types. This surface functionalization approach was applied to coat constricted microfluidic channels for the intracellular delivery of fluorescently labeled dextran and plasmid DNA, demonstrating significant reductions in the accumulation of cell debris. Taken together, our work demonstrates that lipid bicelles are a useful tool to fabricate antifouling lipid bilayer coatings in cell-squeezing devices, resulting in reduced nonspecific fouling and cell clogging to improve performance.

Indexed as

Lab-On-A-Chip DevicesBiofoulingCell AdhesionCells, CulturedHumansJurkat CellsLipid BilayersMolecular StructureParticle SizeSurface PropertiesLipid Bilayersbicellecell squeezingfoulingintracellular deliverymicrofluidicssupported lipid bilayer

Identifiers

PMID32940030
PMCPMC8188960
OpenAlexW3087517998

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.